Table 4.
Univariate and multivariate analysis of factors to predict PCa on prostate biopsy
| |
Univariate analysis |
Multivariate analysis |
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| ALA (positive/negative) |
6.72 |
3.16-14.29 |
<0.001 |
8.00 |
2.50-25.59 |
<0.001 |
| DRE (abnormal/normal) |
8.00 |
2.89-22.15 |
<0.001 |
1.77 |
0.32-9.38 |
0.52 |
| PSAD (>0.15/<0.15) |
34.20 |
11.63-100.54 |
<0.001 |
28.43 |
8.12-99.58 |
<0.001 |
| % fPSA (>20%/<20%) |
1.57 |
0.71-3.53 |
0.27 |
|
|
|
| PSA (>20/>10, <20/<10) |
2.37 |
1.43-3.95 |
0.001 |
1.97 |
0.81-4.80 |
0.14 |
| TRUS (abnormal/normal) | 13.50 | 3.06-59.66 | 0.001 | 7.35 | 0.52-104.58 | 0.14 |
Abbreviation:OR odds ratio, ALA aminolevulinic acid, DRE digital rectal examination, PSAD PSA density, %fPSA percent free PSA, TRUS transrectal uktrasonography.